Senior insider sale
Chief Operating Officer at AQUESTIVE THERAPEUTICS, INC. — senior position signals high conviction
$775.8K
129.75K shares
What this filing means
JUNG CASSIE plans to sell 129.75K shares of AQUESTIVE THERAPEUTICS, INC. valued at approximately $775.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/15/2025ACC: 0001950047-25-007999
Officer· Chief Operating Officer
Since Mar 2026
129.75K
Shares to sell
$775.8K
Approx. market value
67.58K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
10/15/2025
25KRestricted Stock Units
N/A
3/9/2024
42.58KTotal acquired67.58K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/15/2025 | Exercise of Stock Options Cash | 25K | — |
3/9/2024 | Restricted Stock Units N/A | 42.58K | — |
| Total | 67.58K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
62.18K
Market value
$310.9K
9/4/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
67.58K
Market value
$464.9K
10/15/2025
Total
Units
129.75K
Value
$775.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/4/2025 | 62.18K | $310.9K | — | Completed |
| Planned — Approximate Date | ||||
10/15/2025 | 67.58K | $464.9K | NASDAQ | Planned |
| Total | 129.75K | $775.8K | ||